Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by VelaSmooth Users: Cosmetic Dermatologists

Articles with lock require a subscription to GLG News | Request a free trial
December 17, 2007
Cost is key, but not enough!
Analysis of: Ipsen and Medicis announce submission of Reloxin(R) in aesthetics to the FDA | www.pipelinereview.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
Lowering cost of Botox is key, but not enough to induce patients to undergo Botox treatments.
December 13, 2007
Reloxin Gives Allergan's Botox A Run for the Money!
Analysis of: Ipsen and Medicis announce submission of Reloxin(R) in aesthetics to the FDA | www.pipelinereview.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
For too long Allergan has monopolized the therapeutic and cosmetic market of botulinum toxin type A, and has taken full advantage of that monopoly by raising the price of Botox almost biannually. Reloxin studies are very favorable when compared to Botox, and may even surpass it in one or two aspects....
May 29, 2007
New Organiceuticals May Help Bring Back Beauty!
Analysis of: http://www.nytimes.com/2007/04/26/fashion/26skin.html?_r=1&ref=health&oref=slogin | www.nytimes.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
All that glitters is not gold...but some might be! Anti-oxidants are the promise of saving our "hides"!
May 28, 2007
Couldn't agree more
Analysis of: FDA May Place Ban on OTC Bleaching Creams | www.carefair.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
Keep Hydroquinones Around!
May 17, 2007
Non-Invasive Screening of the Skin
Analysis of: New tool allows noninvasive screening of skin lesions | www.modernmedicine.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
The company hopes to apply for European regulatory approval next year, with U.S. market approval and launch to follow. The current price of the device is 15,000 EUR. This device promises to be a remarkable time and money saver for medicine. Approximately 80-95% of lesions excised by dermatologists prove...
May 17, 2007
Pulsed Dye Vs Excimer Laser for Psoriasis
Analysis of: Psoriasis Challenge: pulsed dye vs. excimer lasers | www.modernmedicine.com
Author: Kenneth Edelson, Owner, Kenneth Edelson, MD
Patient satisfaction is high, but long term effects including possible carcinogenesis remain uncertain. Side effects included blistering, and hyperpigmentation in both groups, but no scarring.

Page : 1 to 6 of 6

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics